2-(Benzyloxy)-1-bromo-6-methoxynaphthalene, 98%, 250mg

5-Bromo-2-chloro-4-fluorobenzaldehyde, 97%, 1g

Metalaxyl>98.0%(GC)5g

iScope IS.1153-PLi/DFi Triocular with Plan IOS objectives and Rackless cross stage (dark field contrast application)

BIS(4-METHOXYPHENYL) DISULPHIDE, 98%, 5g

Ethyl 5-(4-bromophenyl)-2-(trifluoromethyl)furan-3-carboxylate, 95.0%, 1g

beta-Nicotinamide Adenine Dinucleotide oxidized form [for Biochemical Research]>95.0%(HPLC)(T)5g

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 5g

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-(4-formyl-2-methoxyphenoxy)acetamide, 5g

2-chloro-1-[1-(3-chloro-4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]ethanone, 95.0%, 500mg

6-Chloro-4-(cyclopropylamino)nicotinaldehyde, 100mg

tert-Butyl 2,6-dioxomorpholine-4-carboxylate, 98%, 100mg

2,5,8,11,14,17,20-Heptaoxadocosan-22-ol, 95.0%, 1g